Bone Marrow Grafting for Leukemia and Lymphoma

This study is currently recruiting participants.
Verified February 2014 by Stanford University
Information provided by (Responsible Party):
Stanford University Identifier:
First received: September 13, 2005
Last updated: February 12, 2014
Last verified: February 2014

Bone Marrow Grafting for Leukemia and Lymphoma

Condition Intervention
Hematologic Diseases
Procedure: collection and storage of tissue samples for research

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Bone Marrow Grafting for Leukemia and Lymphoma

Resource links provided by NLM:

Further study details as provided by Stanford University:

Biospecimen Retention:   Samples With DNA

Tissue samples will be obtained from subjects undergoing transplantation or donors providing the graft.

Estimated Enrollment: 9999
Study Start Date: March 1988
Estimated Study Completion Date: December 2019
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Graft recipients and donors Procedure: collection and storage of tissue samples for research
Tissue samples include blood draws for the donor and recipient. A bone marrow sample may be obtained from the recipient. If the recipient undergoes a tissue biopsy for clinical reasons, a small fraction may be removed for research purposes. A small fraction of the donor graft may be removed at the time of collection for research.

Detailed Description:

The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.


Ages Eligible for Study:   up to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All hematopoietic cell transplant recipients and donors who agree to participate


Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate

Exclusion Criteria:- Subject does not agree to participate

  Contacts and Locations
Please refer to this study by its identifier: NCT00186147

Contact: Physician Referrals (650) 723-0822

United States, California
Stanford University School of Medicine Recruiting
Stanford, California, United States, 94305
Contact: Physician Referrals    650-723-0822      
Principal Investigator: David Miklos         
Principal Investigator: Robert S Negrin         
Sub-Investigator: Judith Anne Shizuru         
Sub-Investigator: Laura Johnston         
Sub-Investigator: Sandra Jeane Horning         
Sub-Investigator: Karl G. Blume         
Sponsors and Collaborators
Stanford University
Principal Investigator: David Miklos Stanford University
Principal Investigator: Robert S Negrin Stanford University
  More Information

No publications provided

Responsible Party: Stanford University Identifier: NCT00186147     History of Changes
Other Study ID Numbers: BMT19, 13358, BMT19
Study First Received: September 13, 2005
Last Updated: February 12, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hematologic Diseases
Neoplasms by Histologic Type
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases processed this record on April 15, 2014